Literature DB >> 18379341

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder.

Kai Lehtimäki1, Tapani Keränen, Martti Huuhka, Johanna Palmio, Mikko Hurme, Esa Leinonen, Jukka Peltola.   

Abstract

OBJECTIVES: Electroconvulsive therapy (ECT) is regarded as an effective treatment of drug-resistant depression, but its mechanism of action is mostly unknown. We have previously reported that epileptic seizures result in cerebral production of cytokines, which are also reflected in the plasma. In this study, we tested whether ECT is associated with similar acute release of cytokines.
METHODS: The plasma levels of cytokines interleukin (IL) 1beta, IL-1 receptor antagonist, and IL-6 were measured using enzyme-linked immunosorbent assay at several time points after ECT. The study included 9 patients who met the diagnostic criteria of major depression (mean age, 55 years; mean Montgomery-Asberg Depression Rating Scale score, 30).
RESULTS: Our results demonstrate that cytokines IL-1beta and IL-6 are increased at 3- and 6-hour time points after ECT. IL-6 release also correlated to the stimulus dose used, suggesting neuronal depolarization as a mechanism of cytokine release.
CONCLUSIONS: These results indicate that ECT is associated with rapid induction of inflammatory cytokines most likely in the central nervous system, which are also measurable in the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379341     DOI: 10.1097/YCT.0b013e3181571abb

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  18 in total

Review 1.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 2.  Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy.

Authors:  Jiangling Jiang; Jijun Wang; Chunbo Li
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

3.  Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

Authors:  Gavin Rush; Aoife O'Donovan; Laura Nagle; Catherine Conway; AnnMaria McCrohan; Cliona O'Farrelly; James V Lucey; Kevin M Malone
Journal:  J Affect Disord       Date:  2016-06-17       Impact factor: 4.839

Review 4.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

5.  Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.

Authors:  Cinara Ludvig Gonçalves; Helena Mendes Abelaira; Thayse Rosa; Airam Barbosa de Moura; Deise Cristina Veron; Laura Araújo Borba; Maria Eduarda Mendes Botelho; Mariana Pereira Goldim; Leandro Garbossa; Maria Eduarda Fileti; Fabricia Petronilho; Zuleide Maria Ignácio; João Quevedo; Gislaine Zilli Réus
Journal:  Pharmacol Rep       Date:  2021-01-03       Impact factor: 3.024

Review 6.  Evidence for a dysregulated immune system in the etiology of psychiatric disorders.

Authors:  Sinead M Gibney; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

7.  Inflammation and depression treatment response to electroconvulsive therapy: Sex-specific role of interleukin-8.

Authors:  Jennifer L Kruse; Richard Olmstead; Gerhard Hellemann; Benjamin Wade; Janina Jiang; Megha M Vasavada; John O Brooks Iii; Eliza Congdon; Randall Espinoza; Katherine L Narr; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2020-05-29       Impact factor: 19.227

8.  Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.

Authors:  Jennifer L Kruse; Eliza Congdon; Richard Olmstead; Stephanie Njau; Elizabeth C Breen; Katherine L Narr; Randall Espinoza; Michael R Irwin
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 5.906

9.  Electroconvulsive seizures (ECS) do not prevent LPS-induced behavioral alterations and microglial activation.

Authors:  E M van Buel; F J Bosker; J van Drunen; J Strijker; W Douwenga; H C Klein; U L M Eisel
Journal:  J Neuroinflammation       Date:  2015-12-12       Impact factor: 8.322

10.  Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression.

Authors:  Serkan Zincir; Pelin Öztürk; Ali Emrah Bilgen; Filiz İzci; Cihad Yükselir
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-15       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.